Literature DB >> 20562305

Xer1-mediated site-specific DNA inversions and excisions in Mycoplasma agalactiae.

Stefan Czurda1, Wolfgang Jechlinger, Renate Rosengarten, Rohini Chopra-Dewasthaly.   

Abstract

Surface antigen variation in Mycoplasma agalactiae, the etiologic agent of contagious agalactia in sheep and goats, is governed by site-specific recombination within the vpma multigene locus encoding the Vpma family of variable surface lipoproteins. This high-frequency Vpma phase switching was previously shown to be mediated by a Xer1 recombinase encoded adjacent to the vpma locus. In this study, it was demonstrated in Escherichia coli that the Xer1 recombinase is responsible for catalyzing vpma gene inversions between recombination sites (RS) located in the 5'-untranslated region (UTR) in all six vpma genes, causing cleavage and strand exchange within a 21-bp conserved region that serves as a recognition sequence. It was further shown that the outcome of the site-specific recombination event depends on the orientation of the two vpma RS, as direct or inverted repeats. While recombination between inverted vpma RS led to inversions, recombination between direct repeat vpma RS led to excisions. Using a newly developed excision assay based on the lacZ reporter system, we were able to successfully demonstrate under native conditions that such Xer1-mediated excisions can indeed also occur in the M. agalactiae type strain PG2, whereas they were not observed in the control xer1-disrupted VpmaY phase-locked mutant (PLMY), which lacks Xer1 recombinase. Unless there are specific regulatory mechanisms preventing such excisions, this might be the cost that the pathogen has to render at the population level for maintaining this high-frequency phase variation machinery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562305      PMCID: PMC2937384          DOI: 10.1128/JB.01537-09

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  27 in total

1.  Modulation of gene expression by promoter mutants of the lambdacI857/pRM/pR system.

Authors:  Wolfgang Jechlinger; Julia Glocker; Wolfgang Haidinger; Alexander Matis; Michael P Szostak; Werner Lubitz
Journal:  J Biotechnol       Date:  2004-11-18       Impact factor: 3.307

2.  Probing in vivo promoter activities in Mycoplasma pneumoniae: a system for generation of single-copy reporter constructs.

Authors:  Sven Halbedel; Jörg Stülke
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

3.  Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions.

Authors:  B Bhugra; L L Voelker; N Zou; H Yu; K Dybvig
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

Review 4.  Transposition and site-specific recombination: adapting DNA cut-and-paste mechanisms to a variety of genetic rearrangements.

Authors:  B Hallet; D J Sherratt
Journal:  FEMS Microbiol Rev       Date:  1997-09       Impact factor: 16.408

5.  The integrase family of tyrosine recombinases: evolution of a conserved active site domain.

Authors:  D Esposito; J J Scocca
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

6.  Topological selectivity in Xer site-specific recombination.

Authors:  S D Colloms; J Bath; D J Sherratt
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

7.  Versatile use of oriC plasmids for functional genomics of Mycoplasma capricolum subsp. capricolum.

Authors:  Carole Janis; Carole Lartigue; Joachim Frey; Henri Wróblewski; François Thiaucourt; Alain Blanchard; Pascal Sirand-Pugnet
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

8.  Genomic, protein homogeneity and antigenic variability of Mycoplasma agalactiae.

Authors:  M Solsona; M Lambert; F Poumarat
Journal:  Vet Microbiol       Date:  1996-05       Impact factor: 3.293

Review 9.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  First steps towards the genetic manipulation of Mycoplasma agalactiae and Mycoplasma bovis using the transposon Tn4001mod.

Authors:  Rohini Chopra-Dewasthaly; Martina Zimmermann; Renate Rosengarten; Christine Citti
Journal:  Int J Med Microbiol       Date:  2005-01       Impact factor: 3.473

View more
  9 in total

1.  Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host.

Authors:  Rohini Chopra-Dewasthaly; Joachim Spergser; Martina Zimmermann; Christine Citti; Wolfgang Jechlinger; Renate Rosengarten
Journal:  PLoS Pathog       Date:  2017-09-28       Impact factor: 6.823

2.  Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.

Authors:  Rohini Chopra-Dewasthaly; Martina Baumgartner; Erika Gamper; Carmen Innerebner; Martina Zimmermann; Franz Schilcher; Alexander Tichy; Petra Winter; Wolfgang Jechlinger; Renate Rosengarten; Joachim Spergser
Journal:  FEMS Immunol Med Microbiol       Date:  2012-08-21

3.  Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Authors:  Vanya Paralanov; Jin Lu; Lynn B Duffy; Donna M Crabb; Susmita Shrivastava; Barbara A Methé; Jason Inman; Shibu Yooseph; Li Xiao; Gail H Cassell; Ken B Waites; John I Glass
Journal:  BMC Microbiol       Date:  2012-05-30       Impact factor: 3.605

4.  Disruption of the pdhB pyruvate dehydrogenase [corrected] gene affects colony morphology, in vitro growth and cell invasiveness of Mycoplasma agalactiae.

Authors:  Shivanand Hegde; Renate Rosengarten; Rohini Chopra-Dewasthaly
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

5.  Mycoplasma agalactiae ST35: a new sequence type with a minimal accessory genome primarily affecting goats.

Authors:  George Filioussis; Georgios Bramis; Evanthia Petridou; Nektarios D Giadinis; Laurent-Xavier Nouvel; Christine Citti; Joachim Frey
Journal:  BMC Vet Res       Date:  2022-01-11       Impact factor: 2.741

6.  Predominant Single Stable VpmaV Expression in Strain GM139 and Major Differences with Mycoplasma agalactiae Type Strain PG2.

Authors:  Maysa Santos Barbosa; Joachim Spergser; Lucas Miranda Marques; Jorge Timenetsky; Renate Rosengarten; Rohini Chopra-Dewasthaly
Journal:  Animals (Basel)       Date:  2022-01-21       Impact factor: 2.752

7.  Sheep Infection Trials with 'Phase-Locked' Vpma Expression Variants of Mycoplasma agalactiae-Towards Elucidating the Role of a Multigene Family Encoding Variable Surface Lipoproteins in Infection and Disease.

Authors:  Rohini Chopra-Dewasthaly; Andreas Dagn; Christian Lohinger; René Brunthaler; Martina Flöck; Munkhtsetseg Kargl; Shrilakshmi Hegde; Joachim Spergser; Renate Rosengarten
Journal:  Microorganisms       Date:  2022-04-14

8.  Interaction of the putative tyrosine recombinases RipX (UU145), XerC (UU222), and CodV (UU529) of Ureaplasma parvum serovar 3 with specific DNA.

Authors:  Carl-Ulrich R Zimmerman; Renate Rosengarten; Joachim Spergser
Journal:  FEMS Microbiol Lett       Date:  2013-01-31       Impact factor: 2.742

9.  In vitro and in vivo cell invasion and systemic spreading of Mycoplasma agalactiae in the sheep infection model.

Authors:  Shivanand Hegde; Shrilakshmi Hegde; Joachim Spergser; René Brunthaler; Renate Rosengarten; Rohini Chopra-Dewasthaly
Journal:  Int J Med Microbiol       Date:  2014-07-27       Impact factor: 3.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.